Clinical Trial Update: Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating nisIN (nisin) for oral cavity squamous cell carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Cavity Squamous Cell Carcinoma

Drugs mentioned

• Nisin (nisin)

Snippet

Sponsor: University of California, San Francisco | Conditions: Oral Cavity Squamous Cell Carcinoma | Phase 1, Phase 2 | Status: RECRUITING